Top

The outcome of second and third allogeneic conditioned HSCT in patients with non-SCID primary immune deficiency (PID) following primary or secondary graft failure

Inborn Errors Working Party (IEWP)
Type d'étude:
Retrospective Studies
Numéro de l'étude:
8427019
Type de traitement:
Allogeneic
Maladies:
 
Titre court:
Outcome of second allo in non-SCID PID patients
Objectif principal:
 
Principaux critères d'inclusion:
 
Pays:
 
Investigateur principal:
Zohreh Nademi
Coordinateur EBMT de l'étude:
Tiar Sirait
E-mail du coordinateur de l'étude:
iewp@ebmt.org